Demonstrates the mechanism by which CRISPR RNAs and Cas proteins mediate antiviral defense in prokaryotes.
Answers are grounded in this paper and cite their sources.
Provides mechanistic clarity for prokaryotic CRISPR defense; leaves open relevance to clinical gene-editing strategies.
Prokaryotes acquire virus resistance by integrating short fragments of viral nucleic acid into clusters of regularly interspaced short palindromic repeats (CRISPRs). Here we show how virus-derived sequences contained in CRISPRs are used by CRISPR-associated (Cas) proteins from the host to mediate an antiviral response that counteracts infection. After transcription of the CRISPR, a complex of Cas proteins termed Cascade cleaves a CRISPR RNA precursor in each repeat and retains the cleavage products containing the virus-derived sequence. Assisted by the helicase Cas3, these mature CRISPR RNAs then serve as small guide RNAs that enable Cascade to interfere with virus proliferation. Our results demonstrate that the formation of mature guide RNAs by the CRISPR RNA endonuclease subunit of Cascade is a mechanistic requirement for antiviral defense.
No takes yet. Share an insight, caveat, or question.
Brouns et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: